Showing results (371-380 of 588) with videos related to

Sort By:
Pageof 59
Cancer Immunology, Immunotherapy : CII|October 4, 2016
Killer immunoglobulin-like receptor (KIR) and KIR-ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2Wei Wang, Amy K Erbe, Mikayla Gallenberger, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer statesJackson Nyman, Thomas Denize, Ziad Bakouny, et al.
Molecular Cancer Therapeutics|October 22, 2017
AKT1low Quiescent Cancer Cells Promote Solid Tumor GrowthCleidson P Alves, Ipsita Dey-Guha, Sheheryar Kabraji, et al.
Clinical Genitourinary Cancer|December 3, 2014
A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancerKevin D Courtney, Judith B Manola, Aymen A Elfiky, et al.
The American Journal of Surgical Pathology|September 27, 2006
A working group classification of focal prostate atrophy lesionsAngelo M De Marzo, Elizabeth A Platz, Jonathan I Epstein, et al.
Cancer Discovery|December 16, 2016
Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast CancersSarah Naomi Olsen, Ania Wronski, Zafira Castaño, et al.
Nature Medicine|February 16, 2010
An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaBJunxia Min, Alexander Zaslavsky, Giuseppe Fedele, et al.
The American Journal of Clinical Nutrition|January 29, 2016
Dietary lycopene intake and risk of prostate cancer defined by ERG protein expressionRebecca E Graff, Andreas Pettersson, Rosina T Lis, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2017
Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicingTeng Fei, Yiwen Chen, Tengfei Xiao, et al.
American Journal of Epidemiology|April 30, 2025
Long-term performance of the Gleason score in predicting metastatic and fatal prostate cancerZhike Lin, Konrad H Stopsack, Michelangelo Fiorentino, et al.
Pageof 59